Antibody therapies set to transform respiratory syncytial virus prevention for babies

Elie Dolgin

Nature, 2023, vol. 621, issue 7980, S55-S57

Abstract: Drugs that counter RSV infection can safeguard newborns, offering another mode of protection alongside vaccines.

Keywords: Drug discovery; Health care; Medical research; Vaccines (search for similar items in EconPapers)
Date: 2023
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/d41586-023-02957-z Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:621:y:2023:i:7980:d:10.1038_d41586-023-02957-z

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/d41586-023-02957-z

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().